Argyria and decreased kidney function: are silver compounds toxic to the kidney?
Mayr
Michael
M
Clinic for Transplantation Immunology and Nephrology, University Hospital, Basel, Switzerland. mmayr@uhbs.ch
Kim
Min Jeong
MJ
Wanner
Daniel
D
Helmut
Hopfer
H
Schroeder
Josef
J
Mihatsch
Michael J
MJ
D001129:Argyria / Q000150:complications* / Q000473:pathology; D001706:Biopsy; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006801:Humans; D007668:Kidney / Q000503:physiopathology* / Q000648:ultrastructure; D007677:Kidney Function Tests; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D051437:Renal Insufficiency / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D018030:Silver Compounds / Q000009:adverse effects*; D012867:Skin / Q000473:pathology
D018030:Silver Compounds